Showing results (2631-2640 of 3,088) with videos related to

Sort By:
Pageof 309
Drug Safety|March 23, 2011
Today's challenges in pharmacovigilance: what can we learn from epoetins?Hans C Ebbers, Aukje K Mantel-Teeuwisse, Ellen H M Moors, et al.
Drug Safety|March 23, 2011
Patient experiences of serious adverse drug reactions and their attitudes to medicines: a qualitative study of survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UKTehreem F Butt, Anthony R Cox, Helen Lewis, et al.
Drug Safety|January 21, 2011
Incidence of infusion-associated reactions with rituximab for treating multiple sclerosis: a retrospective analysis of patients treated at a US centreBrandon A Brown, Mina Torabi
Drug Safety|January 21, 2011
Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformationsRachel A Charlton, John G Weil, Marianne C Cunnington, et al.
Drug Safety|October 15, 2010
Drug-induced hypoglycaemia: an updateChaker Ben Salem, Neila Fathallah, Houssem Hmouda, et al.
Drug Safety|October 8, 2010
Preventability of drug-related harms - part I: a systematic reviewRobin E Ferner, Jeffrey K Aronson
Drug Safety|October 8, 2010
Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactionsJeffrey K Aronson, Robin E Ferner
Drug Safety|October 8, 2010
Temporal data mining for adverse events following immunization in nationwide Danish healthcare databasesHenrik Svanström, Torbjörn Callréus, Anders Hviid
Drug Safety|October 8, 2010
Pharmacists' interventions in prescribing errors at hospital discharge: an observational study in the context of an electronic prescribing system in a UK teaching hospitalDerar H Abdel-Qader, Lindsay Harper, Judith A Cantrill, et al.
Drug Safety|October 8, 2010
Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centreHélène Théophile, Yannick Arimone, Ghada Miremont-Salamé, et al.
Pageof 309